chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Erythematous, itchy deltoid & arm elbow to deltoid quarter size area of papular rash at injection site. Rx CLARITIN 10 mg qd OTC hydrocortisone cream.
Moderna COVID-19 Vaccine. 2nd pregnancy, no history of complications, due date 8/31/21 Low grade fever (99.8 F) around 6pm on 1/19, chills, extreme fatigue, nausea. 1/20 fatigue, nausea. 1/21 vomiting starting at 8am continuing until about 4pm (5 incidents). This is the only day in my pregnancy thus far with vomiting. nausea continuing .
Initial report received from a health care professional (nurse) on 25 May 2010: This patient was vaccinated with MENVEO (batch no: 100001), (dose: unknown) on an unspecified date. The patient was administered MENVEO that was reconstituted with sterile water and not with the active diluent. This had occurred twice. No other information provided at the time of this report.
Initially after vaccination on 1/3/21, the injection site was warm to the touch, red, and slightly swollen.  On the day after the injection (1/4/21), the area of redness and swelling had increased to about 3 times the original size and there is significant pain when moving my arm. It also feels like there is a heavy weight/lump inside my muscle where the injection was given.  The red swollen area has continued to increase in size and the pain has also persisted. It hurts to lift my arm and move it, as well as hurting when I bend over (chest muscle pulling on my arm muscle).  To date, I have been taking (3) Advil thrice daily to manage the pain, as well as apply Aspercreme twice daily to managing nerve pain.
Large itchy rash on arm surrounding injection site. Antihistamines and anti-itch cream applied. Lasted about 4-5 days before clearing.
pt seen in ER 14APR95, t104.4-shakiness-sz activity-stiff; dx febrile synd;inoculation rxn, sz activity
I began having pain on my right side in September. I went to the doctor and received an ultrasound and found out there was some inflammation of my right side. I then got a CT of my right side and more inflammation was found. In mid-Jan 2022 they did a procedure found out that my biliary duct was inflamed.
Swelling to injection site 3x3 round raised. Orapred + Altabax
severe fatigue, stiff joints, muscle weakness, low grade fever, severe headaches, pain to injection site, swollen lymph nodes
MORE SENSITIVE TO THE CHEMICAL METHYLISOTHIAZOLINONE AFTER RECEIVING THE VACCINE; LOSING HAIR (HAIR COMING OUT AS WELL); EXTREMELY DRY SKIN PEELS OFF DUE TO THE DRYNESS; CONTINUE BURNING SENSATION; RED BURNING ITCHY RASH ALL OVER ENTIRE BODY LOOKED LIKE IT HAD BEEN SUNBURNT WITH BLISTERS LIKE HAD BEEN IN A BUNCH OF POISON IVY; This spontaneous report received from a consumer concerned a 71 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no allergies before. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 06-APR-2021, the patient experienced losing hair (hair coming out as well). On 06-APR-2021, the patient experienced extremely dry skin peels off due to the dryness. On 06-APR-2021, the patient experienced continue burning sensation. On 06-APR-2021, the patient experienced red burning itchy rash all over entire body looked like it had been sunburnt with blisters like had been in a bunch of poison ivy. On 12-JUL-2021, Laboratory data included: Allergy test (NR: not provided) Showed allergy to Methylisothiazolinone. On 14-JUL-2021, Laboratory data included: Allergy test (NR: not provided) Showed allergy to Methylisothiazolinone. On 16-JUL-2021, Laboratory data included: Allergy test (NR: not provided) Showed allergy to Methylisothiazolinone. On 15-SEP-2021, treatment medications included: dupilumab. On an unspecified date, the patient experienced more sensitive to the chemical methylisothiazolinone after receiving the vaccine. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Results not known, and Skin biopsy (NR: not provided) One of the biopsies came back as drug induced allergy. Additional treatment medications (dates unspecified) included: hydroxychloroquine, and prednisone. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from more sensitive to the chemical methylisothiazolinone after receiving the vaccine, losing hair (hair coming out as well), extremely dry skin peels off due to the dryness, continue burning sensation, and red burning itchy rash all over entire body looked like it had been sunburnt with blisters like had been in a bunch of poison ivy. This report was non-serious.
She got her vaccine, within an hour she had severe itching, head to toe.  She took Benadryl and Claritin and that did not help.  She called her allergist who put her on steroids and the itching did resolve and go away.  She did have her 2nd vaccine on 2/3/21 and had no itching from that and the arm pain, minor body aches that resolved within 24 hours.  Then around mid April, 4/17/21, she started getting knee, hip and ankle pain.  She is a very active person and started noticing she had a lot of pain and had to keep sitting due to the pain.  She ended up going to PT as she felt maybe she had pulled something.  Went to an orthopedist and then PT, which she is still going to.  They are giving her exercises and they are not helping her and still having the pain after that.  They could not tell her what is going on and no diagnosis for her symptoms.
Accidentally gave Pediatric dose Hep A  to an adult. No adverse reaction noted.
passed out at home; Migraine; chills; aches; tired; slight temp; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received the second dose of bnt162b2, via an unspecified route of administration, administered in right arm on 12Apr2021 (Lot Number: EW0151) as single dose for covid-19 immunisation. Medical history included High cholesterol, hypothyroidism. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2, at the age of 63-year-old, via an unspecified route of administration, administered in left arm on 20Mar2021 18:30 (Lot Number: ER8727) as single dose for covid-19 immunisation. The patient was not pregnant. The patient experienced migraine, chills, aches, slight temp and tired on 13Apr2021 10:00; passed out at home 22:30 13Apr2021. No treatment received. The outcome of the events was recovered in Apr2021.
1st dose pre Covid (2 years ago), 2nd dose on 19Jul2022; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine  (received a single dose pre covid).   On 19th July 2022, the patient received the 2nd dose of Shingles vaccine. On 19th July 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 11-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient did not saw his/her physician for 2 years. The patient stated that they were not sure if this would be considered a first dose because of the duration of the initial or if this second. Additional supportive information: The patient received 2nd dose of Shingles vaccine later than the recommended interval, which led to lengthening of vaccine schedule. The follow-up could not be possible as no contact details were available.
Large swelling, redness, pain, muscle pain, nausea, shivering. 109.1° temperature
1736-First dose of COVID Pfizer Vaccine received ;  1740-Patient c/o itching all over and was actively scratching her self.  Patient related she took a Zyrtec prior to arrival in anticipation of a reaction; 1745-Increased work of breathing by patient, reports feeling like she "just climbed a flight of stairs" 1748-Patient arrived in ED for further evaluation from clinic.
1) March 19, 2021: Intestinal discomfort and diarrhea for 2 weeks. Treated with over the counter drugs and food (BRAT diet).  Resolved after 2 weeks.  2) April 10, 2021: Urinary Tract Infection, urine lab test, antibiotics, not resolved yet. Still have cramps and will follow-up with my doctor. I have NEVER had a UTI before.
Information has been received from a consumer concerning her almost 15 month old daughter with no known medical history who on 05-FEB-2009 was vaccinated with a dose of VARIVAX (Merck).  Concomitant therapy included vitamins (unspecified).  The consumer stated that a few days post vaccination the patient developed a reaction at the injection site of her right arm; there was a small pin prick at the site.  Then a few days later this developed into a bigger, red, swollen area.  She also had a few faint red marks on her face.  The physician was not able to tell if the marks on her face were chickenpox.  The patient sought medical attention went to the office.  At the time of reporting the patient had not recovered.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/15/2009. Follow up information was received from a physician. It was reported that on 05-FEB-2009, the patient with good general health was vaccinated with a first dose of VARIVAX (Merck) (Lot # 661969/1392X) in the right arm and with a second dose of FLUZONE, Lot # UT2783DA) into the right leg. On 14-FEB-2009, the patient had a welt on the right upper arm, there was no vessicle. The welt resolved quickly. There were no labs/diagnostics performed. Additional information is not expected.
Site: Pain at Injection Site-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Dad says "The right arm is inflamed, red and warm when touched. Father brings him to the clinic, I observed red area, inflamed and hot to the touch. I refer to tele consultation with pediatrician.
Swelling & pain at injection site. Onset approx 8 hrs after injection. Patient self administered "ADVIL", applied cold compress the following morning.
Large sore bruise at vaccination site,  swollen sore lymph node near left shoulder, headache for about 36 hours afterwards,
Within a day of getting shot area felt sore, went away after a few days, then returned. 3 weeks after shot arm is sore and hurts to lift too high. After talking with RPh will seek Dr visit ASAP.
General periodic nausea, which we believe could be low blood pressure but that wasn't the case. We think it's acid reflux. I had nausea before, but it got worse after the vaccination. I still have a little bit of nausea but I'm taking pills for acid reflux, 1 daily pill of Dexilant, which appears to be working. I had nausea periodically before the vaccination, but afterwards it was pretty much every day of not feeling good.
Mom states pt was not very happy until MN-crying, eating poorly, vomited x 1, t103.3; mom took pt to MD w/sz; observed x 24 hrs- no sz observed there; dx w/ear infect placed on ATB;
Fever, diarrhea, very sore arm, severe muscle aches in arms and legs, headache, could not sleep lasting on and off for 48 hours.  Was not told I received the High dose shot and have taken flu shots for more than 10 years and never before had any reactions.
5 days after vaccination, left arm got progressively more sensitive to the tough. Rash appeared along spinal column, on chest, and on left shoulder blade by day 6 after vaccination. Rash turned more pustular, with increased sensitivity and needling feeling. On day 9, diagnosed with herpes zoster reactivation (shingles).
Unresponsive 30+ minutes, continued symptoms: jerking movements,(2+weeks) weakness in legs (2+ weeks), seizures (2+ weeks), loss of eye contact ( 1 week), vacant look (1+week). Doctors testing for infantile spasms and encephalopathy as a result of vaccination. 7/30/08-Records received for DOS 7/10-office visit C/O fussy with milk based formula, diarrhea, gassy, irritable. Milk intolerance. 7/14/08- episode of not responsive, tried to change diaper still not responsive. 7/15/08-questionable twitching, jerky motion, odd behavior. 7/17/08-unbalanced, weak, per parent. Questionable early onset spasms vs benign infantile myoclonus.  treated with IVIG, most likely immunologic response exacerbated by immunizations. 9/18/08-records received for DOS 7/19/08-DX: infant spasms 1/25/2010 Delayed speech, heavy metal toxicity.
sore arm, occasionally and headache or mild fever; sore arm, occasionally and headache or mild fever; sore arm, occasionally and headache or mild fever; This spontaneous report has been received from a consumer referring to itself, a currently 59-year-old patient of unspecified gender.  The patient's current conditions, medical history, drug reactions or allergies and concomitants therapies were not reported.  On an unspecified date, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R-II) for prophylaxis (strength, dosage, vaccination scheme frequency, route of administration, anatomical site of injection, lot number and expiration date were not provided).   On an unspecified date, the patient also reported to be vaccinated with influenza vaccine, covid-19 vaccine, diphtheria vaccine toxoid (+) tetanus vaccine toxoid (reported as DT), typhoid vaccine, varicella zoster vaccine rge (cho) (SHINGRIX) and yellow fever vaccine (strengths, dosages, vaccination scheme frequencies, routes of administration, anatomical sites of injection, indications, lot numbers and expiration dates were not provided). On an unspecified date, the patient experienced the standard symptoms of a sore arm (vaccination site pain) and occasionally a headache or a mild fever (pyrexia).  The outcome of the events was unknown.        Causality assessment between the suspect vaccines and the events was assessed as related.
Pt vaccinated with TD experienced local erythema with sterile abscess formation at the site of injection after receiving TD.
mom states hives started on cheek & w/in an hr were all over body;also described a rash on body;mom called clinic when noticed hives-denied pt showed any s&s of diff or change in breathing status-told to call MD;DPH given;4AUG95 rash gone
patient had woken up 08/09/2020 with signs of a rash ranging from her face down to her torso. She is not complaining of any other symptoms or discomfort other than the rash. I had instructed her to take otc benadryl for the rash and we would follow-up with her physician
On 11/10/21 there was a rapid onset of severe pain radiating down right side of neck, shoulders, down right side of right arm. With the progression I noticed more and more weakness extending from the neck, spine, both arm pits and down the arms. I noticed weakness in muscles especially on right side of arms, elbows, hands, wrists and shoulders.   Legs were week and caused frequent falls. The pain was unbearable and I had no idea what was causing this until Dr. diagnosed the PTS.  A few days after the booster I felt a sudden severe pain in my right shoulder that radiated down the right side.  The pain persists until this day.   I?ve tried ice and heat to no avail.  Lately I?ve felt burning and sensitivity and pain shooting down to my wrists. On 1/23/23  pain began on left side of upper arm. Pain is severe and radiates down to fingertips.
Administration error - Patient mistakenly received Pfizer COVID Vaccine for 1st dose and Moderna COVID Vaccine for 2nd dose. Also the patient received the 2nd dose after only 14 days. CDC does not recommend any additional COVID vaccine to be administered at this time. Patient arrived mistakenly at the clinic one week before he was scheduled. Staff did not catch the mistake and continued on with administration.
The patient has local erythema, edema (50mm x 100mm), and the site is warm to the touch. He is being seen and treated here at the Clinic by one of the IDCs.
Attendee with a hx of anxiety, started to exhibit dizziness after she received her first dose of the Pfizer vaccine, was taken to a cot to lay down with legs elevated staff stating she felt very flushed but staff noted not abnormalities to skin. BP taken 100/60 HR 86, bp monitored x2 more times with an increase of BP and HR noted.  EMS called.
The pt experienced chronic extreme pain in ribs, joint and muscle pain, fatigue, nausea. Treated with Prozac, Darvon. Symptoms still persist.
Area of redness 5 1/2" x 5 1/2" surrounding injection site for 2 days. Treatment with Augmentin (600/g) for 10 days.
Caller reported PROQUAD administered after temperature excursion.   PROQUAD Lot # U029325  3/19/2023 experienced 2 excursions during a 24 hour period.  One dose was administered after first excursion but before the second excursion occurred therefore; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 11-APR-2022, the patient was vaccinated with an improperly stored of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, subcutaneously, for prophylaxis (lot # U029325 has been verified to be a valid lot number measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date reported and establish as 19-MAR-2023) (strength and anatomical location were not provided).  The temperature of storage and time frame of the excursion were -13.3° Celsius (C) for 1 hour and 19 minutes respectively.  If a digital data logger was involved was not reported. If a digital data logger was involved was not reported.  The vaccine did not experience a previous temperature excursion.
I'm a seventy year-young male. My complaint is that within 48-hours of the injection, I incurred a hearing loss of at least 3db of sensitivity as a direct result of symptoms similar to the actual contraction of a cold or flu virus; that is, the experience of or the actual fluid accumulation in the inner ear. As of today, 10/22/2019, I still have the symptoms. Indeed, I was never provided a written warning of the latter side-affect by the pharmacist who performed the injection. In a follow-up telephone discussion with my personal physician's RN assistant, she stated that the hearing loss and inner-ear fluid accumulation are temporary. I was glad to hear that because currently I have the attitude that I was injected with poison and am somewhat angry that I was not warned of the possible side-effects of the High Dose option I was injected with. In all of the previous years of October/November flu inoculations, I have never experienced cold or flu symptoms; and probably because I was administered a standard dose on previous occasions.
Information has been received from a nurse practitioner concerning a female with chronic obstructive pulmonary disease and diabetes who had received PNEUMOVAX 23 "multiple times in the past". In November 2009, "last week" the patient was vaccinated intramuscularly with a dose of PNEUMOVAX 23 (lot # 664653/1337Y, 0.5ml). Subsequently the patient developed a "hot, tender, inflamed area" at the injection site. The patient was examined in the clinic and was diagnosed with cellulitis. The patient was prescribed an unspecified antibiotic. There was no laboratory test performed. At the time of the report, the outcome was unknown. Follow up information has been received from a physician concerning a 64 year old female patient with only chronic illness and no known drug allergies who on 10-NOV-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot # 664653/1337Y) in her left deltoid. Subsequently the patient experienced local cellulitis. The patient was treated with KEFLEX 500mg 810x10, ULTRAM and MOTRIN. On 19-NOV-2009, follow up information noted that the patient was recovered. Follow up information has been received from the physician concerning a 64 year old female patient with chronic obstructive pulmonary disease, diabetes mellitus non-insulin-dependent, dyslipidaemia and no known drug allergies who on 10-NOV-2009 was vaccinated with the second dose of PNEUMOVAX 23 (lot # 664653/1337Y) in her left deltoid. On 11-NOV-2009 (previously reported as 10-NOV-2009) the patient experienced sterile cellulitis. On 12-NOV-2009 3x5 warm, erythema area below the deltoid was seen. The patient was treated with KEFLEX 500mg every 6 hours for 10 day, ULTRAM 50mg every 6 hours (duration not reported) and MOTRIN 800mg every 8 hours (duration not reported). At the time of the report, the patient had recovered. No further information is available. This is one of two reports received from the same source.
Two weeks after my 2nd shot my period started twice as heavy as normal. Since having children I have had relatively light and short mentrual cycles with no cramping. June July and august were very heavy and accompanied by painful cramps. I was changing regular tampons out every 2-3 hours. Nothing else changed in my life, same diet etc., I?ma stay at home mom. September and October cycles seem to be getting back to normal; September being heavier. June - August , the bleeding lasted 5 -6 days. It is now back to 3-4 days which is how it has been for the last 9 years.
diabetes - straight to insulin dependent; stroke in one the veins in one of my eyes.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TYPE 1 DIABETES MELLITUS (medically significant), outcome "unknown", described as "diabetes - straight to insulin dependent"; OCULAR VASCULAR DISORDER (medically significant), outcome "unknown", described as "stroke in one the veins in one of my eyes.".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
flu; Initial information received on 31-Jan-2021 regarding an unsolicited valid non-serious social media case received from a consumer via social media.  This case involves a 65 years old patient gender unknown who experienced flu (influenza), while he/she received INFLUENZA VACCINE.  The patient's medical treatments, vaccinations, concomitant medications and family history were not provided.   It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date once about 30 years ago, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer batch number and expiry date not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date 30 years ago, the patient developed a non-serious flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Reported Adverse Event Information: Since this is a public comment on an influencer post for the campaign. The 65 years old patient have only gotten the flu shot once about 30 years ago. Got the flu 30 years ago. Have not gotten the shot or the flu since.   It is unknown if the patient experienced any additional symptoms/ events.   Medication Details and reason for taking the medicine: Not provided.  It is unknown if there were lab data/ results available.  It was not reported if the patient received any corrective treatment.  The outcome of event was unknown, at the time of reporting.  There will be no information on the batch number for this case.